XML 67 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of significant components of the company's deferred tax asset
   
December 31,
   
December 31,
   
December 31,
 
   
2024
   
2023
   
2022
 
   
USD thousands
   
USD thousands
   
USD thousands
 
Net operating loss carry-forward*
   
40,755
     
38,258
     
36,550
 
Share-based compensation expense
   
351
     
1,163
     
1,774
 
Research and development costs
   
3,103
     
4,041
     
2,858
 
Other
   
10
     
9
     
13
 
Gross deferred tax assets
   
44,219
     
43,471
     
41,195
 
Less - Valuation allowance
   
(44,219
)
   
(43,471
)
   
(41,195
)
                         
Net deferred tax assets
   
-
     
-
     
-
 
 
* This excludes capital losses of approximately $14,224 thousands for which the company will create a full valuation allowance.
Schedule of roll forward of valuation allowance
   
USD thousands
 
Balance at December 31, 2021
 
$
36,030
 
Currency translation Income
   
(1,316
)
Income tax expense
   
6,481
 
Balance at December 31, 2022
 
$
41,195
 
Currency translation Income
   
(3,295
)
Income tax expense
   
5,571
 
Balance at December 31, 2023
 
$
43,471
 
Currency translation Income
   
(2,459
)
Income tax expense
   
3,207
 
Balance at December 31, 2024
   
44,219
 
Schedule of reconciliation of theoretical income tax expense to actual income tax expense
   
December 31,
   
December 31,
   
December 31,
 
   
2024
   
2023
   
2022
 
   
USD thousands
   
USD thousands
   
USD thousands
 
                   
Loss before income taxes
   
(13,945
)
   
(24,221
)
   
(28,180
)
Statutory tax rate
   
23
%
   
23
%
   
23
%
Theoretical tax benefit
   
(3,207
)
   
(5,571
)
   
(6,481
)
                         
Change in temporary differences for which deferred taxes were not recognized
   
858
     
(1,177
)
   
(1,696
)
Tax rate differential
   
9
     
10
     
20
 
Non-deductible expenses
   
148
     
346
     
744
 
Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards
   
2,192
     
6,392
     
6,879
 
Actual income tax expense (Benefit)
   
-
     
-
     
(534
)